Troponin T, B-type natriuretic peptide, C-reactive protein, And cause-specific mortality

Annals of Epidemiology

Volumn 23, Issue 2, 2013, Pages 66-73

  Oluleye, Oludamilola W ^a   Folsom, Aaron R ^a   Nambi, Vijay ^b   Lutsey, Pamela L ^a   Ballantyne, Christie M ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

B natriuretic peptide; Biomarkers; C reactive protein; Mortality; Troponin T

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN T;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESPIRATION DISORDERS; RISK FACTORS; TROPONIN T;

EID: 84872159583     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.11.004     Document Type: Article

References (52)

1. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
2. DeFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
3. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
4. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002, 106:416-422.
5. Marz W., Tiran B., Seelhorst U., Wellnitz B., Bauersachs J., Winkelmann B.R., et al. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem 2007, 53:1075-1083.
6. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002, 106:2913-2918.
7. Kragelund C., Gronning B., Kober L., Hildebrandt P., Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005, 352:666-675.
8. Zethelius B., Berglund L., Sundstrom J., Ingelsson E., Basu S., Larsson A., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116.
9. Blankenberg S., McQueen M.J., Smieja M., Pogue J., Balion C., Lonn E., et al. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006, 114:201-208.
10. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813-1818.
11. Buckley D.I., Fu R., Freeman M., Rogers K., Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151:483-495.
12. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140. Emerging Risk Factors Collaboration.
13. Koenig W., Khuseyinova N., Baumert J., Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem 2008, 54:335-342.
14. Ridker P.M. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin Chem 2008, 54:234-237.
15. Wannamethee S.G., Welsh P., Lowe G.D., Gudnason V., Di Angelantonio E., Lennon L., et al. N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011, 58:56-64.
16. Kistorp C. Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics?. Circulation 2006, 114:184-186.
17. Budweiser S., Luchner A., Jorres R.A., Heinemann F., Hitzl A.P., Schmidbauer K., et al. NT-proBNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosis. Respir Med 2007, 101:2003-2010.
18. Jeremias A., Gibson C.M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005, 142:786-791.
19. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
20. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
21. Lutsey P.L., Steffen L.M., Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008, 117:754-761.
22. White A.D., Folsom A.R., Chambless L.E., Sharret A.R., Yang K., Conwill D., et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996, 49:223-233.
23. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H., McGovern P.G., Howard G., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999, 30:736-743.
24. Avery C.L., Mills K.T., Chambless L.E., Chang P.P., Folsom A.R., Mosley T.H., et al. Long-term association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study. Eur J Heart Fail 2010, 12:232-238.
25. Agarwal S.K., Avery C.L., Ballantyne C.M., Catellier D., Nambi V., Saunders J., et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem 2011, 57:891-897.
26. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52:450-459.
27. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
28. de Lemos J.A., Grundy S.M. Low levels of circulating troponin as an intermediate phenotype in the pathway to heart failure. J Am Coll Cardiol 2012, 59:490-492.
29. Rubin J., Matsushita K., Ballantyne C.M., Hoogeveen R., Coresh J., Selvin E. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol 2012, 59:484-489.
30. Wallace T.W., Abdullah S.M., Drazner M.H., Das S.R., Khera A., McGuire D.K., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006, 113:1958-1965.
31. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
32. Kavsak P.A., Xu L., Yusuf S., McQueen M.J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011, 57:1146-1153.
33. Brekke P.H., Omland T., Smith P., Soyseth V. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 2008, 102:1243-1247.
34. Hoiseth A.D., Neukamm A., Karlsson B.D., Omland T., Brekke P.H., Soyseth V. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 2011, 66:775-781.
35. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021.
36. Linssen G.C., Bakker S.J., Voors A.A., Gansevoort R.T., Hillege H.L., de Jong P.E., et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 2010, 31:120-127.
37. Laukkanen J.A., Kurl S., Ala-Kopsala M., Vuolteenaho O., Ruskoaho H., Nyyssonen K., et al. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men. Eur Heart J 2006, 27:1230-1237.
38. Olsen M.H., Hansen T.W., Christensen M.K., Gustafsson F., Rasmussen S., Wachtell K., et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 2007, 28:1374-1381.
39. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004, 350:655-663.
40. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005, 293:1609-1616.
41. Nilsson J.C., Groenning B.A., Nielsen G., Fritz-Hansen T., Trawinski J., Hildebrandt P.R., et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J 2002, 143:696-702.
42. Abdullah S.M., Khera A., Das S.R., Stanek H.G., Canham R.M., Chung A.K., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 2005, 96:1284-1289.
43. Doi Y., Ninomiya T., Hata J., Hirakawa Y., Mukai N., Ikeda F., et al. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study. Arterioscler Thromb Vasc Biol 2011, 31:2997-3003.
44. D'Souza S.P., Baxter G.F. B Type natriuretic peptide: a good omen in myocardial ischaemia?. Heart 2003, 89:707-709.
45. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993, 88:82-91.
46. Takahashi T., Nakamura M., Onoda T., Ohsawa M., Tanno K., Itai K., et al. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis 2009, 207:298-303.
47. Nogami M., Shiga J., Takatsu A., Endo N., Ishiyama I. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J 2001, 33:87-90.
48. Idris I., Hill R., Ross I., Sharma J.C. N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. Age Ageing 2010, 39:752-755.
49. Ambrus J.L., Ambrus C.M., Mink I.B., Pickren J.W. Causes of death in cancer patients. J Med 1975, 6:61-64.
50. Cardinale D., Colombo A., Sandri M.T., Lamantia G., Colombo N., Civelli M., et al. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation 2007, 115:1339-1344.
51. Dolci A., Dominici R., Cardinale D., Sandri M.T., Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol 2008, 130:688-695.
52. Lee S., Choe J.W., Kim H.K., Sung J. High-sensitivity C-reactive protein and cancer. J Epidemiol 2011, 21:161-168.